GlassScriptPhysician profile
Jeffrey L Benjamin
NPI 1740274588
$3,116.48
in general payments reported to CMS, 2019-2025
30 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $202 · 2021: $311 · 2022: $327 · 2023: $595 · 2024: $350 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,241.29 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Teva Pharmaceuticals USA, INC. | $227.00 | 2019-2024 | Austedo Xr |
| Allergan, INC. | $206.37 | 2019-2022 | |
| Medtronic, INC. | $200.74 | 2023 | |
| Novartis Pharmaceuticals Corporation | $149.21 | 2019 | |
| Ucb, INC. | $135.68 | 2019 | |
| Genzyme Corporation | $98.10 | 2019-2023 | |
| Mdd US Operations, LLC | $84.49 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $77.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $72.37 | 2024-2025 | |
| Grifols USA, LLC | $66.68 | 2019 | |
| Emd Serono, INC. | $59.45 | 2019 | |
| Greenwich Biosciences, INC. | $48.03 | 2019 | |
| Amneal Pharmaceuticals LLC | $44.61 | 2019 | |
| Avanos Medical | $43.62 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $41.27 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $38.31 | 2023 | Firdapse |
| Eisai INC. | $37.59 | 2019 | |
| Mallinckrodt Enterprises LLC | $33.15 | 2019 | |
| Csl Behring | $28.05 | 2019 | |
| Ge Healthcare | $28.03 | 2019 | |
| Lundbeck LLC | $25.38 | 2019 | |
| Springworks Therapeutics, INC. | $24.58 | 2025 | Gomekli |
| Avanir Pharmaceuticals, INC. | $22.79 | 2019 | |
| Amgen INC. | $16.13 | 2019 | |
| Almatica Pharma LLC | $15.08 | 2023 | Gralise |
| Lilly USA, LLC | $14.01 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.57 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.50 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.